Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119167) titled 'A multicenter, randomized, double-blind, positive drug and placebo parallel-controlled Phase II clinical study evaluating the efficacy, safety, and pharmacokinetic characteristics of a single administration of QP-6211 injection in subjects undergoing open unilateral hallux valgus correction surgery' on Feb. 24.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Jishuitan Hospital
Condition:
Postoperative pain
Intervention:
Group 1:Low dose of QP-6211
Group 2:High doses of QP-6211
Group 3:Sodium chloride injection
Recruitment Status: Not Recruiting
Phase: 2
Date of First ...